TIFFANY POTTKOTTER: Open Payments
NPI 1629271150 · UPPER SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 45 payments from 17 companies in 2025. Trend: 2023 $352 · 2024 $469 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $148 |
| Axsome Therapeutics, Inc. | 6 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| Biogen, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
Products named: VRAYLAR, Auvelity, REXULTI, ENTYVIO, INGREZZA, ZURZUVAE, CAPLYTA, SPRAVATO.
Industry payments across OH — which companies pay providers there.
